GAA
CRL icon

Global Assets Advisory’s Charles River Laboratories CRL Stock Holding History

Global Assets Advisory’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-114
Closed -$30.6K – 151
2024
Q1 		$30.6K Buy
+114
New +$27.2K 0.02% 351

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Global Assets Advisory's CRL Position: Q2 2024 in Review

Global Assets Advisory sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 114 shares — an estimated $30.6K sold.

Global Assets Advisory first reported a position in CRL in Q1 2024 and held it in 1 quarter. The position peaked at $30.6K in Q1 2024. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • Global Assets Advisory reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • Global Assets Advisory sold 114 Charles River Laboratories shares in Q2 2024, an estimated $30.6K.
  • Global Assets Advisory first reported a position in Charles River Laboratories in Q1 2024 and held it in 1 quarter.
  • Global Assets Advisory's Charles River Laboratories position peaked at $30.6K in Q1 2024.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Global Assets Advisory's 13F filing for Q2 2024, filed 30 Jul 2024.